|
Eli Lilly and Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$1018
|
$944B |
14.8x |
32.7x |
|
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$249
|
$627B |
6.7x |
17.5x |
|
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$234
|
$476B |
7.8x |
18.2x |
|
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$121
|
$335B |
5.2x |
11.2x |
|
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$386
|
$253B |
7.0x |
14.3x |
|
Thermo Fisher Scientific
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Supplies
|
$509
|
$220B |
5.0x |
19.7x |
|
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$150
|
$202B |
6.9x |
12.6x |
|
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$27
|
$201B |
3.2x |
8.1x |
|
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$62
|
$163B |
3.4x |
8.7x |
|
Danaher
|
United States of America |
Medical Devices,
Laboratory Services,
Medical Supplies
|
$206
|
$161B |
6.6x |
21.0x |
|
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$486
|
$119B |
9.9x |
22.0x |
|
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$791
|
$77.7B |
5.5x |
15.5x |
|
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$129
|
$61.4B |
6.5x |
14.9x |
|
IDEXX Laboratories
|
United States of America |
Medical Devices,
Laboratory Services,
Healthcare Software
|
$637
|
$51.5B |
12.0x |
34.5x |
|
IQVIA
|
United States of America |
Contract Research & Manufacturing,
Health Data & Analytics,
Healthcare Software
|
$174
|
$43.4B |
2.7x |
11.5x |
|
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$325
|
$41.5B |
11.1x |
59.1x |
|
Agilent
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Imaging & Diagnostics
|
$118
|
$35.0B |
5.1x |
17.3x |
|
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$16
|
$31.6B |
2.2x |
7.7x |
|
Waters
|
United States of America |
Laboratory Services,
Medical Devices
|
$307
|
$31.0B |
9.8x |
27.4x |
|
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$146
|
$30.7B |
59.7x |
-27.4x |
|
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$188
|
$30.4B |
3.1x |
10.0x |
|
Labcorp
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$286
|
$29.6B |
2.1x |
12.3x |
|
Quest Diagnostics
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$210
|
$29.1B |
2.7x |
13.3x |
|
Mettler Toledo
|
United States of America |
Laboratory Services,
Medical Devices
|
$1325
|
$29.0B |
7.3x |
23.2x |
|
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$47
|
$27.8B |
9.3x |
9.6x |
|
Natera
|
United States of America |
Genomics & Personalized Medicine,
Medical Imaging & Diagnostics
|
$200
|
$27.1B |
12.2x |
-81.7x |
|
Exact Sciences
|
United States of America |
Medical Imaging & Diagnostics,
Genomics & Personalized Medicine
|
$103
|
$21.3B |
6.6x |
44.7x |
|
Illumina
|
United States of America |
Genomics & Personalized Medicine,
Laboratory Services
|
$133
|
$21.2B |
5.0x |
17.8x |
|
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$514
|
$19.0B |
5.9x |
11.4x |
|
Revolution Medicines
|
United States of America |
Drug Development & Therapeutics
|
$102
|
$17.9B |
4648.8x |
-15.8x |
|
Insulet
|
United States of America |
Medical Devices,
Drug Delivery Systems
|
$245
|
$17.5B |
6.5x |
27.1x |
|
Elanco
|
United States of America |
Drug Development & Therapeutics
|
$26
|
$16.5B |
3.5x |
18.5x |
|
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$53
|
$16.4B |
8.6x |
-5.1x |
|
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$100
|
$16.4B |
3.3x |
10.3x |
|
Roivant Sciences
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$28
|
$15.7B |
854.2x |
-14.0x |
|
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$190
|
$14.7B |
3.5x |
15.6x |
|
BridgeBio Pharma
|
United States of America |
Drug Development & Therapeutics
|
$65
|
$14.0B |
28.3x |
-30.5x |
|
Revvity
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics,
Health Data & Analytics
|
$96
|
$13.2B |
4.6x |
15.5x |
|
Regencell Bioscience
|
United States of America |
Drug Development & Therapeutics
|
$26
|
$13.0B |
N/A |
N/A |
|
Guardant Health
|
United States of America |
Medical Imaging & Diagnostics,
Genomics & Personalized Medicine
|
$92
|
$12.6B |
13.0x |
-59.5x |
|
Medpace
|
United States of America |
Contract Research & Manufacturing,
Medical Devices
|
$457
|
$12.6B |
5.0x |
22.8x |
|
Ionis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$82
|
$12.5B |
14.0x |
-33.9x |
|
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$132
|
$12.2B |
4.3x |
18.5x |
|
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$16
|
$11.9B |
N/A |
-11.6x |
|
ICON plc
|
United States of America |
Contract Research & Manufacturing,
Healthcare Software,
Health Data & Analytics
|
$108
|
$11.3B |
1.4x |
7.2x |
|
Charles River
|
United States of America |
Contract Research & Manufacturing,
Laboratory Services
|
$179
|
$11.1B |
2.8x |
11.8x |
|
ImmunityBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$10
|
$11.0B |
99.2x |
N/A |
|
Qiagen
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$49
|
$10.6B |
5.1x |
13.9x |
|
BioMarin Pharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$60
|
$10.6B |
3.3x |
14.3x |
|
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$70
|
$10.2B |
7.6x |
11.7x |
|
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$107
|
$10.2B |
3.3x |
-8.3x |
|
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$7
|
$9.9B |
1.6x |
5.2x |
|
Exelixis
|
United States of America |
Drug Development & Therapeutics
|
$41
|
$9.8B |
4.2x |
10.4x |
|
Bio-Techne
|
United States of America |
Laboratory Services,
Pharma Diagnostics & Analytics
|
$58
|
$9.2B |
7.5x |
21.5x |
|
Madrigal Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$436
|
$9.1B |
9.6x |
-31.0x |
|
Praxis Precision Medicines
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$337
|
$9.1B |
30365.3x |
-30.5x |
|
Axsome Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$166
|
$8.4B |
13.4x |
-51.3x |
|
Arrowhead Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$64
|
$8.4B |
11.6x |
209.7x |
|
Ingredion
|
United States of America |
Food & Beverages,
Plant-Based Food
|
$117
|
$8.3B |
1.1x |
6.6x |
|
Cytokinetics
|
United States of America |
Drug Development & Therapeutics
|
$61
|
$7.7B |
96.2x |
-12.8x |
|
Vaxcyte
|
United States of America |
Vaccines & Immunotherapies
|
$62
|
$7.3B |
N/A |
-8.6x |
|
Nuvalent
|
United States of America |
Drug Development & Therapeutics
|
$102
|
$7.0B |
N/A |
-16.9x |
|
Repligen
|
United States of America |
Contract Research & Manufacturing,
Laboratory Services
|
$125
|
$7.0B |
9.5x |
50.2x |
|
Kymera Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$91
|
$6.9B |
129.1x |
-21.8x |
|
RadNet
|
United States of America |
Medical Imaging & Diagnostics,
Laboratory Services
|
$75
|
$6.9B |
3.4x |
23.2x |
|
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$14
|
$6.8B |
2.3x |
10.0x |
|
Krystal Biotech
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$259
|
$6.8B |
17.4x |
40.2x |
|
Sotera Health
|
United States of America |
Laboratory Services,
Medical Supplies
|
$16
|
$6.5B |
5.6x |
10.9x |
|
Belite Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$178
|
$6.4B |
N/A |
N/A |
|
PTC Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$66
|
$6.3B |
3.5x |
6.6x |
|
Arcellx
|
United States of America |
Drug Development & Therapeutics
|
$114
|
$6.2B |
189.6x |
-24.6x |
|
Rhythm Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$95
|
$6.1B |
32.3x |
-31.7x |
|
Cogent Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$39
|
$5.7B |
N/A |
-21.3x |
|
Protagonist Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$94
|
$5.5B |
84.6x |
-37.2x |
|
Mirum Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$90
|
$5.3B |
10.5x |
-338.8x |
|
Lantheus Holdings
|
United States of America |
Medical Imaging & Diagnostics,
Drug Development & Therapeutics
|
$76
|
$5.3B |
3.5x |
9.8x |
|
Immunovant
|
United States of America |
Drug Development & Therapeutics
|
$28
|
$4.9B |
N/A |
-9.7x |
|
Celcuity
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$108
|
$4.9B |
N/A |
-29.4x |
|
Perrigo
|
United States of America |
Health & Beauty,
Drug Development & Therapeutics
|
$12
|
$4.8B |
1.1x |
6.6x |
|
TG Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$29
|
$4.8B |
7.9x |
34.6x |
|
Amicus Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$14
|
$4.7B |
7.4x |
43.9x |
|
Stevanato Group
|
United States of America |
Medical Supplies,
Drug Delivery Systems
|
$15
|
$4.5B |
3.3x |
13.2x |
|
Terns Pharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$42
|
$4.3B |
N/A |
-38.1x |
|
Apogee Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$70
|
$4.3B |
N/A |
-15.1x |
|
Prestige Consumer Healthcare
|
United States of America |
Health & Beauty,
Drug Development & Therapeutics
|
$69
|
$4.3B |
3.8x |
11.6x |
|
CG Oncology
|
United States of America |
Drug Development & Therapeutics
|
$59
|
$4.2B |
1542.2x |
-21.4x |
|
Scholar Rock
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$43
|
$4.2B |
N/A |
-10.5x |
|
CRISPR Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$61
|
$4.1B |
504.8x |
-7.3x |
|
Erasca
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$14
|
$4.0B |
N/A |
-27.7x |
|
Alkermes
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$30
|
$4.0B |
2.7x |
10.4x |
|
Nomad Foods
|
United States of America |
Food & Beverages,
Plant-Based Food
|
$11
|
$3.8B |
1.1x |
6.2x |
|
Ligand Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$203
|
$3.8B |
14.2x |
35.2x |
|
ADMA Biologics
|
United States of America |
Biopharmaceuticals
|
$16
|
$3.7B |
7.3x |
15.9x |
|
Structure Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$63
|
$3.7B |
N/A |
-13.3x |
|
Corcept Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$36
|
$3.5B |
4.3x |
23.9x |
|
Alumis
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$30
|
$3.4B |
135.3x |
-13.8x |
|
Arcutis Biotherapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$27
|
$3.2B |
9.0x |
-1681.7x |
|
Kiniksa Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$46
|
$3.1B |
4.7x |
29.4x |
|
Viking Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$33
|
$3.1B |
N/A |
-9.4x |
|
NewAmsterdam Pharma Co
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$33
|
$3.1B |
115.0x |
-14.9x |